Logo image of AXIL

AXIL BRANDS INC (AXIL) Stock Fundamental Analysis

USA - NYSEARCA:AXIL - US76151R2067 - Common Stock

6.2 USD
+0.03 (+0.49%)
Last: 10/23/2025, 8:04:03 PM
6.4 USD
+0.2 (+3.23%)
After Hours: 10/16/2025, 8:04:03 PM
Fundamental Rating

4

Taking everything into account, AXIL scores 4 out of 10 in our fundamental rating. AXIL was compared to 33 industry peers in the Personal Care Products industry. Both the profitability and the financial health of AXIL get a neutral evaluation. Nothing too spectacular is happening here. AXIL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year AXIL was profitable.
In the past year AXIL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AXIL reported negative net income in multiple years.
Of the past 5 years AXIL 4 years had a positive operating cash flow.
AXIL Yearly Net Income VS EBIT VS OCF VS FCFAXIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1M 2M 3M

1.2 Ratios

The Return On Assets of AXIL (8.46%) is better than 75.76% of its industry peers.
The Return On Equity of AXIL (12.74%) is better than 75.76% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.33%, AXIL is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AXIL is in line with the industry average of 12.77%.
Industry RankSector Rank
ROA 8.46%
ROE 12.74%
ROIC 10.33%
ROA(3y)18.32%
ROA(5y)2.18%
ROE(3y)26.5%
ROE(5y)-21.11%
ROIC(3y)12.34%
ROIC(5y)N/A
AXIL Yearly ROA, ROE, ROICAXIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

AXIL has a better Profit Margin (4.77%) than 66.67% of its industry peers.
The Operating Margin of AXIL (6.29%) is comparable to the rest of the industry.
AXIL's Gross Margin of 70.14% is in line compared to the rest of the industry. AXIL outperforms 57.58% of its industry peers.
AXIL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.29%
PM (TTM) 4.77%
GM 70.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y6.21%
AXIL Yearly Profit, Operating, Gross MarginsAXIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AXIL is still creating some value.
AXIL has more shares outstanding than it did 1 year ago.
AXIL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AXIL has been reduced compared to a year ago.
AXIL Yearly Shares OutstandingAXIL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
AXIL Yearly Total Debt VS Total AssetsAXIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 7.67 indicates that AXIL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.67, AXIL belongs to the top of the industry, outperforming 93.94% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that AXIL is not too dependend on debt financing.
AXIL's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. AXIL outperforms 69.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 7.67
ROIC/WACC1.2
WACC8.59%
AXIL Yearly LT Debt VS Equity VS FCFAXIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 2.59 indicates that AXIL has no problem at all paying its short term obligations.
AXIL has a better Current ratio (2.59) than 63.64% of its industry peers.
A Quick Ratio of 1.73 indicates that AXIL should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.73, AXIL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 1.73
AXIL Yearly Current Assets VS Current LiabilitesAXIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AXIL have decreased strongly by -32.96% in the last year.
The Revenue has been growing slightly by 0.07% in the past year.
The Revenue has been growing by 91.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-32.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%328.09%
Revenue 1Y (TTM)0.07%
Revenue growth 3Y124.01%
Revenue growth 5Y91.75%
Sales Q2Q%17.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AXIL Yearly Revenue VS EstimatesAXIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AXIL is valuated quite expensively with a Price/Earnings ratio of 41.33.
AXIL's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.67. AXIL is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 41.33
Fwd PE N/A
AXIL Price Earnings VS Forward Price EarningsAXIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

AXIL's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.86
AXIL Per share dataAXIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AXIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXIL BRANDS INC

NYSEARCA:AXIL (10/23/2025, 8:04:03 PM)

After market: 6.4 +0.2 (+3.23%)

6.2

+0.03 (+0.49%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-09 2025-10-09
Earnings (Next)01-06 2026-01-06
Inst Owners11.37%
Inst Owner Change0%
Ins Owners22.3%
Ins Owner Change0%
Market Cap41.91M
Revenue(TTM)27.26M
Net Income(TTM)1.30M
AnalystsN/A
Price TargetN/A
Short Float %0.16%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 41.33
Fwd PE N/A
P/S 1.54
P/FCF N/A
P/OCF 143.44
P/B 4.11
P/tB 5.52
EV/EBITDA 19.86
EPS(TTM)0.15
EY2.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.04
OCFY0.7%
SpS4.03
BVpS1.51
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.26
Profitability
Industry RankSector Rank
ROA 8.46%
ROE 12.74%
ROCE 15.81%
ROIC 10.33%
ROICexc 16.58%
ROICexgc 26.99%
OM 6.29%
PM (TTM) 4.77%
GM 70.14%
FCFM N/A
ROA(3y)18.32%
ROA(5y)2.18%
ROE(3y)26.5%
ROE(5y)-21.11%
ROIC(3y)12.34%
ROIC(5y)N/A
ROICexc(3y)28.55%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.89%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y6.21%
F-Score2
Asset Turnover1.78
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.07
Cap/Depr 226.1%
Cap/Sales 1.64%
Interest Coverage 357.04
Cash Conversion 15.29%
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 1.73
Altman-Z 7.67
F-Score2
WACC8.59%
ROIC/WACC1.2
Cap/Depr(3y)152.48%
Cap/Depr(5y)122.29%
Cap/Sales(3y)0.79%
Cap/Sales(5y)0.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%328.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.07%
Revenue growth 3Y124.01%
Revenue growth 5Y91.75%
Sales Q2Q%17.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-106.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.35%
OCF growth 3YN/A
OCF growth 5YN/A